These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 16222604)

  • 1. Treating high blood pressure in diabetes: the evidence.
    Adler AI
    Semin Vasc Med; 2002 May; 2(2):127-37. PubMed ID: 16222604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New treatment guidelines for a patient with diabetes and hypertension.
    Mogensen CE
    J Hypertens Suppl; 2003 Mar; 21(1):S25-30. PubMed ID: 12769164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Choice of antihypertensive drug in the diabetic patient.
    Ong HT; Cheah JS
    MedGenMed; 2005 May; 7(2):74. PubMed ID: 16369452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of hypertension and diabetes: prevalence, cardiovascular risk and protection by blood pressure reduction.
    Mancia G
    Acta Diabetol; 2005 Apr; 42 Suppl 1():S17-25. PubMed ID: 15868115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Success of blood pressure reduction in diabetic patients].
    Schernthaner G
    Dtsch Med Wochenschr; 2006 Dec; 131 Suppl 8():S247-51. PubMed ID: 17139580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microalbuminuria: a common, independent cardiovascular risk factor, especially but not exclusively in type 2 diabetes.
    Donnelly R; Yeung JM; Manning G
    J Hypertens Suppl; 2003 Mar; 21(1):S7-12. PubMed ID: 12769161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 'Beyond blood pressure' means multiple risk factor intervention, not pleiotropic antihypertensive drugs.
    Staessen JA; Thijs L; Li Y; Kuznetsova T; Richart T; Wang J; Birkenhäger WH
    Curr Opin Cardiol; 2007 Jul; 22(4):335-43. PubMed ID: 17556887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of the ADVANCE study for clinical practice.
    Zannad F
    J Hypertens Suppl; 2008 Sep; 26(3):S29-32. PubMed ID: 19363850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is treatment of hypertension with acetylcholine esterase inhibitors (ACEIs) superior to other antihypertensives in preventing significant cardiovascular events and death in patients with type 2 diabetes?
    McConaghy JR
    J Fam Pract; 2000 Nov; 49(11):980. PubMed ID: 11093559
    [No Abstract]   [Full Text] [Related]  

  • 12. The importance of blood pressure control in the patient with diabetes.
    Bakris GL
    Am J Med; 2004 Mar; 116 Suppl 5A():30S-38S. PubMed ID: 15019861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hypertension and diabetes].
    Bouhanick B; Laboureau-Soares Barbosa S; Marre M
    Arch Mal Coeur Vaiss; 2000 Nov; 93(11 Suppl):1429-34. PubMed ID: 11190292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood pressure-lowering drugs: essential therapy for some patients with normal blood pressure.
    Fuchs FD
    Expert Rev Cardiovasc Ther; 2004 Sep; 2(5):771-5. PubMed ID: 15350178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hypertension in patients with diabetes].
    Poulsen PL; Hansen KW; Gaede PH; Rossing P
    Ugeskr Laeger; 2009 Jun; 171(24):2031-4. PubMed ID: 19523370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of hypertension in peripheral arterial disease: does the choice of drugs matter?
    Singer DR; Kite A
    Eur J Vasc Endovasc Surg; 2008 Jun; 35(6):701-8. PubMed ID: 18375152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertension and diabetes: epidemiologic aspects as a guide to management.
    Fuller JH
    J Cardiovasc Pharmacol; 1993; 21 Suppl 2():S63-6. PubMed ID: 7692153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-converting enzyme inhibition by perindopril in the treatment of cardiovascular disease.
    Brugts JJ; Ferrari R; Simoons ML
    Expert Rev Cardiovasc Ther; 2009 Apr; 7(4):345-60. PubMed ID: 19379059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of blood pressure control and angiotensin-converting enzyme inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: a post hoc analysis of the BENEDICT trial.
    Ruggenenti P; Perna A; Ganeva M; Ene-Iordache B; Remuzzi G;
    J Am Soc Nephrol; 2006 Dec; 17(12):3472-81. PubMed ID: 17082240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Managing hypertension in high-risk patients: lessons and promises from the STRATHE and ADVANCE trials.
    Waeber B
    J Hypertens Suppl; 2006 May; 24(3):S19-27. PubMed ID: 16723862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.